Sageworth Trust’s ResMed RMD Stock Holding History

Sageworth Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2	Closed	–	–	314
2020 Q2	$0	Buy	+2	New	+$327	﹤0.01%	317
2018 Q1	–	Sell	-3	Closed	–	–	160
2017 Q4	$0	Buy	+3	New	+$248	﹤0.01%	136

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sageworth Trust's RMD Position: Q3 2020 in Review

Sageworth Trust sold out of ResMed (RMD) in Q3 2020, closing a stake of 2 shares.

Sageworth Trust first reported a position in RMD in Q4 2017 and held it in 2 quarters. The position peaked at $0 in Q2 2020. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

Sageworth Trust reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
Sageworth Trust sold 2 ResMed shares in Q3 2020.
Sageworth Trust first reported a position in ResMed in Q4 2017 and held it in 2 quarters.
Sageworth Trust's ResMed position peaked at $0 in Q2 2020.
626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Sageworth Trust's 13F filing for Q3 2020, filed 4 Nov 2020.